PPI
PPI is a pharmaceutical drug with 18 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
91.7%
11 of 12 finished
8.3%
1 ended early
2
trials recruiting
18
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate the Effect of Food, Formulation, and a Proton Pump Inhibitor (PPI) on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-003)
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children
Delirium Related to Proton Pump Inhibitors Use
Dietary Supplement With and Without a Probiotic
Clinical Trials (18)
A Study to Evaluate the Effect of Food, Formulation, and a Proton Pump Inhibitor (PPI) on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-003)
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children
Delirium Related to Proton Pump Inhibitors Use
Dietary Supplement With and Without a Probiotic
Emulation of Randomized Clinical Trial in Cardiovascular Disease
Shaeer's Vein Ligation-I: Internal Pudendal Vein Sub-Gluteal Ligation For Veno Occlusive Erectile Dysfunction
Shaeer's Vein Ligation-II: Internal Pudendal Vein Perineal Ligation For Veno Occlusive Erectile Dysfunction
Relative Bioavailability and Drug-drug Interaction Study With MT-7117 and a Proton Pump Inhibitor
The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise
A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)
The EndoGastric Solutions TEMPO Trial
Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease
A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)
A New System for GERD Diagnosis and Treatment
PPI Versus Placebo in Severe Functional Heartburn
The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients
Surgicel® Fibrillar for Delayed Bleeding After ESD
All 18 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 18